Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey

Radiologic–pathologic discordance in biopsy-proven usual interstitial pneumonia

(2016) Kunihiro Yagihashi et al.   EUROPEAN RESPIRATORY JOURNAL

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Idiopathic pulmonary fibrosis: Early detection and referral

(2014) Justin M. Oldham et al.   RESPIRATORY MEDICINE

Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis

(2012) Luca Richeldi et al.   THORAX

Delayed Access and Survival in Idiopathic Pulmonary Fibrosis

(2011) Daniela J. Lamas et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis

(2011) Roland M. du Bois et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Living with idiopathic pulmonary fibrosis

(2011) Gadi Schoenheit et al.   Chronic Respiratory Disease

Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis

(2009) C. J. Zappala et al.   EUROPEAN RESPIRATORY JOURNAL